Defibrotide Injection Drug Interactions
- Defitelio
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
About Defibrotide Injection
Defibrotide injection is used to treat adults and children with hepatic veno-occlusive disease (VOD; blocked blood vessels inside the liver, also known as sinusoidal obstruction syndrome), who have kidney or lung problems after receiving a hematopoietic stem-cell transplant (HSCT; procedure in which certain blood cells are removed from the body and then retu…
Read the full Defibrotide Injection drug information pageQuick links
The Bottom Line on Defibrotide Injection
Defibrotide is given by injection to adults and children whose liver's small blood vessels have become blocked after a stem-cell transplant, and who are also having kidney or lung trouble. It helps open up those vessels again.
This medicine has more documented interactions than most, and about half of them are rated major or contraindicated. Bleeding is the problem that comes up most. Aspirin and apixaban are both rated contraindicated with it, because each raises the chance of bleeding.
Since your care team is managing a lot at once, ask the pharmacist at the counter before you buy any new supplement or over-the-counter product.
From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy
Check Defibrotide Injection Against Another Drug or Supplement
Type a drug, a brand name or a supplement. We check it against every documented defibrotide injection interaction, supplements and herbs included.
What Could Happen When Defibrotide Injection Interacts
What the 87 documented defibrotide injection interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.
This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site. One interaction can name more than one problem, so the numbers add up to more than 87.
Defibrotide Injection Interactions by Severity
Contraindicated
- Defibrotide Injection and Abciximab Explained Increased risk of bleeding Details
- Defibrotide Injection and Acenocoumarol Explained Increased risk of bleeding Details
- Defibrotide Injection and Alteplase, Recombinant Explained Brand name: Activase Increased risk of bleeding Details
- Defibrotide Injection and Anagrelide Explained Brand name: Agrylin Increased risk of bleeding Details
- Defibrotide Injection and Anistreplase Explained Increased risk of bleeding Details
- Defibrotide Injection and Apixaban Explained Brand names: Eliquis, ELIQUIS 30-Day Starter Pack, Eliquis Sprinkle Increased risk of bleeding Details
- Defibrotide Injection and Ardeparin Explained Increased risk of bleeding Details
- Defibrotide Injection and Argatroban Explained Increased risk of bleeding Details
- Defibrotide Injection and Aspirin Explained Brand names: Entercote, Zorprin, Valomag Increased risk of bleeding Details
- Defibrotide Injection and Bemiparin Explained Increased risk of bleeding Details
- Defibrotide Injection and Bivalirudin Explained Brand name: Angiomax Increased risk of bleeding Details
- Defibrotide Injection and Certoparin Explained Increased risk of bleeding Details
- Defibrotide Injection and Cilostazol Explained Brand name: Pletal Increased risk of bleeding Details
- Defibrotide Injection and Clopidogrel Explained Brand name: Plavix Increased risk of bleeding Details
- Defibrotide Injection and Dabigatran Etexilate Explained Brand name: Pradaxa Increased risk of bleeding Details
- Defibrotide Injection and Dalteparin Explained Brand name: Fragmin Increased risk of bleeding Details
- Defibrotide Injection and Danaparoid Explained Increased risk of bleeding Details
- Defibrotide Injection and Desirudin Explained Brand name: Iprivask Increased risk of bleeding Details
- Defibrotide Injection and Dipyridamole Explained Brand names: Persantine, Permole Increased risk of bleeding Details
- Defibrotide Injection and Edoxaban Explained Brand name: Savaysa Increased risk of bleeding Details
Look Up Another Drug
Still Have Questions About Defibrotide Injection?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
The References Behind Defibrotide Injection’s Interactions
The 157 sources our defibrotide injection interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →
- Bonifazi F, Sica S, Angeletti A, et al: Veno-occlusive disease in HSCT patients: consensus-based recommendations for risk assessment, diagnosis, and management by the GITMO Group. Transplantation 2021; 105(4):686-694. PubMed
- Corbacioglu S, Cesaro S, Faraci M, et al: Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 2012; 379(9823):1301-1309.
- Jazz Pharmaceuticals: Jazz Pharmaceuticals stops enrollment in phase 3 study evaluating defibrotide for the prevention of veno-occlusive disease. Jazz Pharmaceuticals. Dublin, Ireland. 2020.
- Kayikci O, Akpinar S, & Tekgunduz E: Effectiveness of defibrotide in the prevention of hepatic venooclusive disease among adult patients receiving allogeneic hematopoietic cell transplantation: a retrospective single center experience. Transfus Apher Sci 2022; 61(1):103369. PubMed
- Picod A, Bonnin A, Battipaglia G, et al: Defibrotide for sinusoidal obstruction syndrome/veno-occlusive disease prophylaxis in high-risk adult patients: a single-center experience study. Biol Blood Marrow Transplant 2018; 24(7):1471-1475. DOI
- Cheuk DK, Chiang AK, Ha SY, et al: Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. Cochrane Database Syst Rev 2015; 2015(5):CD009311. PubMed
- Product Information: DEFITELIO(R) intravenous injection, defibrotide sodium intravenous injection. Jazz Pharmaceuticals (per FDA), Palo Alto, CA, 2016. DailyMed
- Richardson PG, Riches ML, Kernan NA, et al: Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 2016; 127(13):1656-1665. PubMed
- Kernan NA, Grupp S, Smith AR, et al: Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br J Haematol 2018; 181(6):816-827.
- Gloude NJ, Jodele S, Teusink-Cross A, et al: Combination of high-dose methylprednisolone and defibrotide for veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2018; 24(1):91-95. PubMed